Sami-Sabinsa Group Limited-Dobaspet Unit FDA Record

Summary

Recent FDA inspections

2 inspections from Jul 28, 2011 to Apr 2, 2024.

NAI

No objectionable conditions or practices were found during the inspection.

VAI

Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.

OAI

Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

FDA-inspected facilities

1 inspected site, newest inspection first.

Sami-Sabinsa Group Limited-Dobaspet Unit and the FDA: common questions

Has Sami-Sabinsa Group Limited-Dobaspet Unit received an FDA warning letter?

No FDA warning letter addressed to the name "Sami-Sabinsa Group Limited-Dobaspet Unit" is on file. This answer covers that name only: letters addressed to a related company name or to one of its sites are listed on that name's or site's own page.

Has Sami-Sabinsa Group Limited-Dobaspet Unit received an FDA Form 483?

FDA has not published a Form 483 for "Sami-Sabinsa Group Limited-Dobaspet Unit" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Sami-Sabinsa Group Limited-Dobaspet Unit?

The most recent FDA inspection on file ended Apr 2, 2024 at Sompura, India and was classified VAI. FDA has 2 inspections of Sami-Sabinsa Group Limited-Dobaspet Unit on file.